Free Trial
NASDAQ:BIS

ProShares UltraShort Nasdaq Biotechnology (BIS) Price, Holdings, & News

$14.42 +0.04 (+0.28%)
Closing price 08/29/2025 03:56 PM Eastern
Extended Trading
$14.42 +0.01 (+0.03%)
As of 08/29/2025 04:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS)

Key Stats

Today's Range
$14.42
$14.55
50-Day Range
$14.05
$18.17
52-Week Range
$13.72
$25.87
Volume
3,360 shs
Average Volume
11,336 shs
Market Capitalization
$2.45 million
Assets Under Management
$2.46 million
Dividend Yield
4.09%
Net Expense Ratio
0.95%
Aggregate Rating
N/A

ETF Overview

ProShares UltraShort Nasdaq Biotechnology Expenses

TypeBISHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.75%0.56%0.56%0.54%0.53%
Other Expenses1.67%0.47%0.56%0.52%0.56%
Total Expense2.42%0.75%0.76%0.73%0.73%
Fee Waiver-1.47%-0.67%-0.66%-0.50%-0.63%
Net Expense0.95%0.60%0.63%0.63%0.60%
Receive BIS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ProShares UltraShort Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BIS ETF News Headlines

Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why
Imagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA or Bitcoin, but by owning a simple index fund. It sounds impossible. Yet it happened – just a short time ago. Now a legendary figure says: "Brace yourselves. It's about to happen here, in America. But fair warning – it could be the worst thing that ever happens to you." This story has received little coverage in the press. But if history repeats, it could bump tens of millions of Americans into a 7-figure net worth practically overnight.tc pixel
BIS ProShares UltraShort Nasdaq Biotechnology ETF
See More Headlines

BIS ETF - Frequently Asked Questions

ProShares UltraShort Nasdaq Biotechnology's stock was trading at $18.19 at the start of the year. Since then, BIS stock has decreased by 20.7% and is now trading at $14.42.

ProShares UltraShort Nasdaq Biotechnology's stock reverse split before market open on Tuesday, August 18th 2020.The 1-4 reverse split was announced on Tuesday, August 4th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Monday, August 17th 2020. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

Shares of BIS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ProShares UltraShort Nasdaq Biotechnology investors own include Micron Technology (MU), Inovio Pharmaceuticals (INO), Sanofi (SNY), Intel (INTC), Meta Platforms (META), NVIDIA (NVDA) and Advanced Micro Devices (AMD).

Fund Details

Issuer
ProShares
Fund Name
ProShares UltraShort Nasdaq Biotechnology
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:BIS
Inception Date
4/6/2010
Fund Manager
Michael Neches, Tarak Dave

Fund Focus

Asset Class
Equity
Benchmark
Nasdaq Biotechnology Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
17

Fund Statistics

Assets Under Management
$2.46 million
Average Daily Volume
$9.05 thousand
Discount/Premium
0.00%
Leveraged
-2.00

Administrator, Advisor and Custodian

Administrator
J.P. Morgan Investor Services Co.
Advisor
ProShare Advisors, LLC
Custodian
JPMorgan Chase Bank, N.A.
Distributor
SEI Investments Distribution Co.
Transfer Agent
J.P. Morgan Chase Bank, N.A.
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
Optionable
Options Volume
1
Put Options
1
Call Options
35
Short Interest
7,400 shs

Miscellaneous

Beta
-1.41
Creation Unit
50,000
Creation Fee
$250.00
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Top 6 BIS Holdings

  • NET OTHER ASSETS (LIABILITIES)
    Holding Weight: 0.00%
  • NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA
    Holding Weight: -30.35%
  • NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG
    Holding Weight: -30.94%
  • NASDAQ BIO INDEX SWAP BNP PARIBAS
    Holding Weight: -39.61%
  • NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE
    Holding Weight: -43.36%
  • NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA
    Holding Weight: -55.77%

This page (NASDAQ:BIS) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners